The number of COVID-19 infections in Hong Kong has been surging in the 5th wave of the outbreak, with 10785 additional confirmed cases and 4721 additional asymptomatic cases as of March 6, according to the updated statistics from the Centre for Health Protection (CHP) of the Department of Health (DH) of Hong Kong.

Immediate Response, Effective Collaboration

Knowing the fact that nucleic acid testing materials were insufficient in Hong Kong, Getein responded quickly and increased the production capacity of antigen test kits by equipment upgrade, process optimization, technology innovation and resources integration, to ensure sufficient supplies to deliver to Hong Kong and help fight the outbreak.

In order to guarantee the timely arrival of anti-epidemic supplies to Hong Kong, Nanjing Customs has taken measures to ship the anti-epidemic materials at the first time by early declaration and rapid inspection.

At present, the first batch of COVID-19 antigen testing kits has been delivered to Hong Kong to meet the most urgent needs of Hong Kong citizens and health-care workers.

Easy and Fast Testing

The product that Getein delivered to Hong Kong is One Step Test for SARS-CoV-2 Antigen (Colloidal Gold), which is very easy and fast to operate. No testing equipment is required. Individuals could perform the test by collecting nasal swab sample themselves. The sampling process is simple and comfortable and the test results can be obtained in just 10-15 minutes.

The convenient operation allows this test to be widely used in many scenarios such as home, workplace, school, etc.

Multiple Certifications, Quality Guaranteed

By now, Getein One Step Test for SARS-CoV-2 Antigen (Colloidal Gold)(for self-test) has received CE certification and been listed in the EU common list. Besides, the test kit has been validated and approved by Thailand FDA, Malaysia MDA, the Philippines FDA and the UK CTDA. In addition, Getein One Step Test for SARS-CoV-2 Antigen (Colloidal Gold) has also passed the PEI evaluation and the phase 3a validation of British DHSC. the phase 3a validation of British DHSC.

At this globally difficult time, Getein Biotech Inc. will continuously focus the pandemic and contribute itself to the prevention and control of the COVID-19 pandemic, to promptly support the resumption of the global work & production as well as the early return of people’s normal life.